Jazz Pharmaceuticals plc Logo

Jazz Pharmaceuticals plc (1JAZZ)

MTA

Currency in EUR
214.40
0.00 (0.00%)

Real-time Data

07:00 AM

Day's Range

214.40
214.40

52 wk Range

103.00
228.30

Overview - 1JAZZ - Jazz Pharmaceuticals plc

Key Statistics

Valuation

Enterprise Value

13.93B

P/E (Trailing)

‪17.12‬

PEG Ratio

‪-0.13‬

Price / Sales (TTM)

‪3.01‬

Price / Book

‪3.37‬

EV / EBITDA

‪8.44‬

Profitability

Gross Margin

‪90.36%‬

Profit Margin

‪20.44%‬

Operating Margin

‪26.91%‬

Return on Assets

‪6.86%‬

Return on Equity

‪22.11%‬

Ownership

Shares Outstanding

64.80M

Float

62.93M

Held by Insiders

‪2.98%‬

Held by Institutions

‪103.03%‬

Price stats

Beta

‪0.36‬

50-Day Avg

‪210.62‬

200-Day Avg

‪172.82‬

Dividends

Payout Ratio

‪0.00%‬

Peers - 1JAZZ - Jazz Pharmaceuticals plc

Peer Comparison

Compared with companies in Biotechnology listed on MTA.

Profile Summary - 1JAZZ - Jazz Pharmaceuticals plc

About

Jazz Pharmaceuticals plc is a biopharmaceutical company dedicated to identifying, developing, and commercializing innovative medicines that address unmet medical needs in serious diseases. It maintains a diverse portfolio of marketed products targeting rare epilepsies such as with Epidiolex, sleep disorders including…

SectorHealthcare
IndustryBiotechnology
Employees2.89K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.